SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

GH Research Names Vanina Popova Chief Development Officer

Popova will lead clinical development of GH001 as the company moves toward pivotal programs in treat.

GHRS

Related stories